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Background: Although many vector-borne diseases are important causes of morbidity and mortality in dogs in
tropical areas and potential zoonoses, there is little information on these conditions in Central America.
Methods: Seven qPCRs for vector-borne pathogens were performed on a Roche LightCycler PCR Instrument to
investigate their prevalence in a convenience sample of whole blood samples from apparently healthy dogs in
Nicaragua. Also, a qPCR targeting the canine hydroxymethylbilane synthase (HMBS) gene was used as an endogenous
internal control and verified the quality and quantity of DNA in the samples was appropriate for the study.
Results: We found DNA of Rickettsia felis (5%), Babesia spp. (26%), Hepatozoon canis (51%), Anaplasma platys (13%) and
Ehrlichia canis (56%) in the 39 dogs studied. The qPCRs for Coxiella burnetii and Dirofilaria immitis were negative. Of the
30 (80%) dogs that were positive by qPCR, 12 (31%) were positive for one agent, 11 (28%) for two, 3 (8%) for three, and
4 (10%) for four agents.
Conclusions: This is the first report of B. gibsoni in dogs from Central America and the first recording of vector-borne
agents in dogs from Nicaragua. Dogs in Nicaragua are commonly infected with a variety of vector-borne pathogens,
some of which may also infect people.
Keywords: Nicaragua, Rickettsia felis, Babesia gibsoni/vogeli, Hepatozoon canis, Anaplasma platys, Ehrlichia canis, Coxiella
burnetii, Dirofilaria immitisBackground
Vector-borne agents are important causes of morbidity
and mortality in dogs worldwide [1-4]. Many cause zoo-
noses and the close relationship between people and
their dogs facilitates human infections. Knowledge of the
prevalences of canine vector-borne disease is thus im-
portant for veterinarians and their patients as well as for
workers in the public health field [5]. There is only very
limited data on vector-borne diseases in dogs from the
seven Central American states with reports from only
three countries, mainly Costa Rica [6-8], Panama [9-11]
and Guatemala [12]. To provide further data on canine* Correspondence: chengmingwang@gmail.com
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unless otherwise stated.vector-borne diseases from the region, we investigated a
convenience sample of dogs from Nicaragua and de-
scribe the findings in this report.Methods
Dogs and blood samples
This study was approved by the Institutional Animal Care
and Use Committee of the Yangzhou University College of
Veterinary Medicine of China. Convenience samples of
whole blood were collected into EDTA from 39 apparently
healthy dogs presented at a neutering program operated
by Volunteers for Intercultural and Definitive Adventure
(VIDA, sites.google.com/site/rusvmvida) in April 2012.
The dogs belonged to local people from underprivileged
areas in Rivas, a city situated in Southwestern Nicaragua.
Verbal permission was received from the owners of the
dogs for blood to be used in the study. The whole blood. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(200 μL) were frozen at −80°C until DNA was extracted as
described below.DNA extraction
The High-Pure PCR Template Preparation Kit (Roche
Molecular Biochemicals, Indianapolis, IN, USA) was used
to extract total nucleic acids from the whole blood ali-
quots as described previously [13]. Each extracted DNA
was eluted in 200 μL elution buffer and stored at −80°C
for qPCRs.Quantitative PCRs
Eight qPCRs, seven for tick-borne pathogens and one for
the canine HMBS gene as an endogenous internal control,
were performed on a Roche LightCycler 480-II PCR Instru-
ment. The qPCRs were performed as described previously
for R. felis [14], Babesia spp. [15], Hepatozoon spp. [16],
Anaplasma spp. [17], E. canis [17], C. burnetii [18] and the
canine HMBS gene [19]. The PCR products were verified
by gel electrophoresis and nucleotide sequencing using for-
ward and antisense primers (GenScript, Nanjing, China).
The Clustal Multiple Alignment Algorithm was used
to compare the GenBank sequences of the 5.8S rRNA of
D. immitis (AF217800,EU087700, EU182331.1, EU182328,
AF217800)and the following primers and probes were
designed specifically for D. immitis and validated: sense
primer: 5′- TTCAATAACTCTAAGCGGGGGATCACCT-
3′; anti-sense primer: 5′- TCTGATCGATATTGACCCT
CAACCAGAC-3′; 6-FAM probe: 5′-TGCAGACGCATT-
GAGCACAAAGATTTC-(6-FAM)-3′; LCRed 640 probe:
5′-(LCRed-640)- AATGCACATTGCACCATCGGGTTGA-
(Phosphate)-3′. The hybridization temperature of the
qPCR was found to be optimal at 58°C and the thermal
cycling protocol was as described previously [17]. A
172-bp nucleotide fragment representing the canine D.
immitis 5.8S rRNA gene sequence was synthesized and
inserted in the pIDTSMART cloning vector (Integrated
DNA Technologies, Coralville, IA, USA) and used as
the quantitative standard for the D. immitis qPCR. The
DNA products were quantified using the PicoGreen®
DNA fluorescence assay (Molecular Probes, Eugene,
OR, USA) and the number of target molecules was cal-
culated. Logarithmic dilutions of the DNA products
were used to determine the sensitivity of the D. immitis
qPCR, which was verified by gel electrophoresis and
nucleotide sequencing (GenScript, Nanjing, China).Statistical analysis
The gene copy numbers determined by qPCRs were
logarithmically transformed for statistical analysis using
the Kruskal-Wallis non-parametric ANOVA.Results and discussion
The limited time available for the neutering program
meant we were unable to carry out detailed investiga-
tions of the ticks found on the dogs. The overall impres-
sion, however, was that ticks were common and
consisted mainly of R. sanguineus group. There was no
regular use of acaricides for ticks and control was mostly
by manual removal when tick burdens were high.
The qPCR for the HMBS gene was positive on all sam-
ples with 2.1 × 106 ± 8.8 × 105 copies/ml whole blood,
indicating successful extraction of amplifiable DNA from
all samples. The qPCR we developed for D. immitis con-
sistently gave positive results with the quantitative stand-
ard we synthesized. Using the standard we found we
could detect a single copy of the 5.8S rRNA gene in a
qPCR reaction.
We obtained positive qPCR results for 5 of the 7 or-
ganisms we tested. Only D. immitis and C. burnetii gave
negative qPCR results in all the dogs we examined. D.
immitis is the agent of canine heartworm disease which
is transmitted by mosquitoes and an important cause of
lung and heart pathology in dogs worldwide [20]. There
is only one report on the disease from Central America
where just 2% of dogs studied in Costa Rica were sero-
positive [7], considerably less than that from the nearby
USA where seroprevalences may be up to 49% [21]. Ab-
sence of animals positive by qPCR in our study could re-
flect the small sample of dogs we tested or represent a
more generalized low level of infection. Further studies
are needed to determine the true status of D. immitis in-
fections in Nicaragua.
C. burnetii is the agent of Q fever in people, a disease
reported to occur worldwide, apart from New Zealand
[22]. Sources of human infections are generally domestic
ruminants although cats have been implicated in some
outbreaks [23] and dogs in only one [24]. There are no
reports of C. burnetii in people or animals in Central
America and we found no evidence of infection in dogs.
Using PCR, however, is not a sensitive method to detect
C. burnetii exposure in dogs or its presence in an area.
In the only other survey for C. burnetii in dog blood
which was conducted in Hungary, just 1/123 samples
was PCR positive despite 25 being seropositive [25]. To
determine the importance of Q fever in Central America,
studies are needed on people and livestock which are the
major reservoirs of infection.
The most common infectious agent we detected was
E. canis (22/39; 56%) with an average of 84 copies of the
16S rRNA gene/ml whole blood (SD 71; range 50 ~ 313)
(Figure 1). This prevalence is similar to the 47% (148/310)
[6] to 34% (50/146) [8] reported from Costa Rica in the
only other PCR surveys of dogs in Central America, and
these findings suggest the organism is prevalent in the re-
gion. Infections with E. canis cause canine monocytic
Figure 1 Gene copy number of five vector-borne pathogens in canine whole blood samples. Quantitative FRET-PCRs determined the gene
copy number of five tick-borne pathogens. The rRNA copy numbers for E. canis (84 ± 71 /per ml whole blood; range 50 ~ 313) were significantly lower
than those for H. canis (72,120 ± 260,148), A. platys (370472 ± 659438; range 651 ~ 1534409), and B. canis (35161 ± 61,335; range 72 ~ 199,552). The gltA
copy number for R. felis (204 ± 125; range 116 and 292) was not significantly different from the rRNA copy number of the other four tick-borne agents.
The Y-axis is shown as logarithmic scale, and the data were shown as average gene copy number (−), mean ± SD (□) and mean ±1.96 × SD (Ι).
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thrombocytopenia [26,27]. We were unable to carry out
hematological examinations on our study dogs but, des-
pite the high likelihood that some were thrombocytopenic,
all the surgeries were uneventful and no abnormal bleed-
ing tendencies were noted.
E. canis is transmitted by the Rhipicephalus sanguineus
group which occurs worldwide [28]. There is no vaccine
for E. canis and only tick control can prevent infections.
Unfortunately, R. sanguineus group is notoriously difficult
to control even with expensive modern acaricides and ap-
plicators. Diagnosing infections is also challenging as, al-
though organisms can be seen in stained blood smears,
microscopy is rarely successful and diagnoses are usually
made with expensive serology and/or PCRs. Even when
diagnoses are made, treatment failures are common in nat-
urally infected dogs [17,29], most probably as a result of in-
adequate tick control and re-infection. The difficulties
associated with tick control, diagnosis and treatment mean
that in underprivileged areas infections with E. canis will be
particularly difficult to control and canine monocytic ehr-
lichiosis can be expected to remain prevalent in these areas.
Although apparently uncommon, E. canis can infect
people [30] and health workers in Central America
should be aware of the high prevalence of ehrlichiosis in
dogs and the possibility of infections in their patients,
particularly those with a history of tick bites [8,9,31].Infections with H. canis were also very common in our
study (20/39; 51%) with an average 18S rRNA copy num-
ber of 72,120/ml whole blood (SD 260,148; range 3 ~
1,171,720) (Figure 1). A lower infection rate was found in
Costa Rica (11/146; 8%) in the only other investigation of
the organism in Central America [8]. Infections have also
been reported from Africa, Southwestern Asia, Southwest-
ern and Eastern Europe and North and South America
[3], indicating a worldwide distribution of the organism.
This is expected as the main vector of H. canis is R. san-
guineus group [32], which occurs worldwide [28]. Most in-
fections are subclinical, but in some dogs (15%) there is
high parasitemia and clinical signs including fever, weight
loss, anemia and hyperglobulinemia [33]. Many dogs
have concurrent infections with vector-borne agents
such as E. canis and Babesia spp., and deciding each
agent’s contribution to signs is difficult. Various treat-
ments have been used but none are fully effective [34].
The predominant Babesia spp. in dogs are B. gibsoni,
B. canis, B. vogeli, and B. rossi [35-37]. In our study we
found 26% of the dogs (10/39) had DNA of Babesia spp.
with an average 18S rRNA copy number of 370,472/ml
whole blood (SD 659,438; range 72 ~ 199,552). Melting
point analysis and genomic sequencing showed four of the
10 dogs to be infected with B. gibsoni (Tm ~67°C) and six
with B. vogeli (Tm ~58°C). None of the dogs were infected
with both species or with B. vogeli or B. rossi. B. gibsoni is
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Europe, the USA and the Caribbean [17] and ours is
the first report of the organism in Central America.
The organism is thought to be transmitted by fighting
or by ticks, in particular R. sanguineus group [38].
There are no reported human infections [39] but in
dogs infections usually result in acute signs including
fever, pallor, splenomegaly and anorexia [39]. Dogs that re-
cover from the acute infection generally become chronic
subclinical carriers with significantly reduced platelet
counts [40]. Diagnosis is by detecting organisms in stained
blood smears but in chronic cases organisms are seldom
seen and serology or PCR are needed [39]. As with canine
ehrlichiosis, treatment of B. gibsoni is difficult and often
the parasite is not eliminated [41].
The other Babesia spp. we detected, B. vogeli, has been
reported from Central America with 8% of 146 dogs
studied in Costa Rica being positive [8]. This organism is
transmitted by R. sanguineus group, with infections be-
ing subclinical or causing only mild signs with anemia
and thrombocytopenia [4]. It has also not been reported
to infect people [38].
Only a few dogs (5/39, 13%) carried A. platys DNA with
an average of 370,472 copies of the 16S rRNA gene/ml
whole blood (SD 659,438; range 651 ~ 1,534,409). This is
similar to the prevalence reported in Costa Rica (14/146:
10%) [8] and indicates the organism is probably widely
distributed in Central America, as it is elsewhere in the
world. A. platys is probably transmitted by R. sanguineus
group and is the agent of infectious canine cyclic
thrombocytopenia [42]. There is only a single report of an
infection in a person [43]. Although infections in dogs are
often subclinical, infected dogs might be thrombocytope-
nic. Platelet numbers might be lower with coinfections
with other vector-borne agents, in particular E. canis and
Babesia spp. [17,44]. Although organisms can be seen in
peripheral blood smears, the most sensitive diagnosis is by
serology or PCR [42]. Treatment with doxycycline has
been reported to sterilize infections [45].
The least common agent we detected was R. felis (2/39,
5%) with gltA copies of 116 and 292/ml of whole blood
(SD 125; range 116 ~ 292). This is an emerging pathogen
principally associated with cat fleas (Ctenocephalides felis)
and responsible for flea-borne spotted fever in people
[46]. The organism occurs on all continents except
Antarctica and has been reported in cat fleas from
Guatemala, Costa Rica and Panama in Central America
[9,47,48]. Recent evidence has indicated dogs might be
reservoir hosts for the organism although infections
seem to be subclinical [14]. Infections in people can
cause clinical signs ,which are generally mild and con-
sist of fever, headache, myalgia and rash [49]. In Africa,
infections appear common with up to 6% of febrile pa-
tients in Kenya and Senegal reported to be PCR positivefor the organism [50]. Although no clinical cases have
been reported from Central America, R. felis appears to
be widespread in the area and health workers should be
aware of the possibility of flea-borne spotted fever in
patients with a history of contact with fleas.
In the 80% (31/39) of dogs we studied which had DNA
of a vector-borne agent, mixed infections were very
common with 11 (28%) having evidence of two agents, 3
(8%) having evidence of three, and 4 (10%) of four agents
(Table 1). The most common multiple infection was
with H. canis and E. canis (7 dogs) with infections with
H. canis, E. canis, B. vogeli and A. platys being second
most common (3 dogs). There is little detailed data on
mixed infections and how one agent may exacerbate
[8,17,44] or ameliorate [51] the effects of another, which
greatly complicated clinical diagnoses. Also it means that
in many dogs multiple drug therapies are needed to cure
animals and resolve hematological and biochemical
abnormalities.
It is particularly noteworthy that many of the patho-
gens we found cause thrombocytopenia in apparently
healthy dogs. The infections are often difficult to diag-
nose without expensive serology and/or PCR, and treat-
ment is often unsuccessful which poses major problems
to local veterinarians carrying out surgeries and organi-
zations carrying out neutering programs in underprivil-
eged areas. Finding innovative and inexpensive methods
for parasite and vector control on dogs appears to be the
best way forward for controlling these vector-borne
pathogens of dogs and people.
The nucleotide sequences of the PCR amplicons we ob-
tained for the five vector-borne pathogens we detected were
identical to those reported previously. The sequences of the
R. felis, B. gibsoni, B. vogeli, H. canis, A. platys and E. canis
amplicons were the same as those reported in GenBank
for organisms from Brazil (Gene Accession #JF694092),
St. Kitts (JX112784), St Kitts (JX112785), Brazil (KF692040),
South Africa (KC189854) and the Czech Republic
(KC479024), respectively.
Comparisons of the average gene copy numbers of the
five vector-borne pathogens we studied showed the
rRNA copy numbers for E. canis were significantly lower
than those for H. canis, B. canis and A. platys (Figure 1;
Kruskal-Wallis non-parametric ANOVA). This probably
reflects the fact that E. canis occurs in monocytes which
are in lower concentrations in the blood than neutro-
phils, erythrocytes and platelets in which the other or-
ganisms are found, respectively. The gltA copy number
for R. felis was not significantly different from the rRNA
copy number of the other four tick-borne agents.
Conclusions
Our study has added to the scant data on canine and
zoonotic vector-borne agents in Central America. We
Table 1 Prevalences of vector-borne agents in dogs deter-




Rickettsia Hepatozoon Babesia Anaplasma Ehrlichia
1 - H. canis B. vogeli A. platys E. canis
2 - - - - E. canis
3 - - - - -
4 - - B. gibsoni A. platys E. canis
5 - - B. gibsoni - -
6 - - B. vogeli - E. canis
7 - H. canis - - E. canis
8 - - - - -
9 - - - - E. canis
10 - H. canis - - -
11 - H. canis - - E. canis
12 R. felis - - - E. canis
13 - H. canis - - E. canis
14 - - - - E. canis
15 - - - - -
16 - H. canis - - E. canis
17 - - - - -
18 - - - - E. canis
19 - - - - -
20 - H. canis B. vogeli A. platys E. canis
21 - H. canis - A. platys -
22 - - - - E. canis
23 - - - - -
24 - H. canis B. vogeli A. platys E. canis
25 - H. canis B. vogeli - E. canis
26 - - - - -
27 - - - - -
28 - H. canis - - E. canis
29 - H. canis - - -
30 - H. canis - - -
31 - H. canis B. gibsoni - -
32 - H. canis - - -
33 - H. canis - - E. canis
34 - - - - -
35 - H. canis B. gibsoni - E. canis
36 - - - - E. canis
37 R. felis H. canis B. vogeli - E. canis
38 - H. canis - - -
39 - H. canis - - E. canis
“-”denotes the absence of examined DNA in the whole blood of the
designated dog.
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Nicaragua and the first report of B. gibsoni in Central
America. The available data from our study and the few
others performed in the region suggest vector-borne dis-
eases of dogs are common and widespread and in need
of further investigation. Also, many of the pathogens can
infect people and health workers need to be aware of
this possibility, particularly in patients that have contact
with dogs and their parasites.
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